PDF(Pubmed)
Abstract：
COVID-19 caused by SARS-CoV2 has reached pandemic proportions. The fear of Covid-19 has deterred many to abandon efforts for seeking timely medical help. In this setting, Obstructive sleep apnea (OSA)-like covid/non-covid cohorts have presented. Atypical pathologies can present like OSA and take the clinician unawares. With this series of misfits suffering silently, it would be unwise to underestimate its impact on quality-of-life (QOL). To determine the effect on quality-of-life by pathologies mimicking OSA and assess Covid-19 as a cause for delayed presentation. This was a prospective cross-sectional study. 127(N). Recent onset of symptoms of OSA. Study duration March 2020 to September 2021. Pittsburgh Sleep Quality Index (PSQI) screening done. Study criteria defined. Sleep parameters calculated. Primary surgical intervention given. Non-responders were put on CPAP therapy. QOL assessment done with sf-36 and SAQLI. Fear of Covid-19 scale (FCV-19S) quantified to study cause for temporal delay. Correlations computed. Level of Evidence-Level 3. 97 candidates completed study. Demographic and anthropometric details noted. Mean range was 43.85 ± 11.39 years. Male predominance. Overall AHI-19.73 ± 8.72. Moderate impact on QOL by sf-36/SAQLI. 78n Primary surgical candidates fared well. Polysomnography (PSG) and Continuous positive airway pressure (CPAP) titration/trial characteristics for 19n available. Statistically significant improvement in QOL after treatment completion. Correlations were meaningful. Body Mass Index (BMI) as a single factor was not influential on OSA-mimickers. Fear of Covid-19 significantly impacted emergency medical aid acquisition. OSA mimicking atypical airway pathologies may need emergent treatment not only from a surgical point-of-view but also from the QOL of the patient. On the contrary, these also unmask sub-clinical OSA, especially in patients with low/normal BMI. This category of recent onset OSA, if fortunately picked up at the earliest possible presentation, may hopefully not go through the significant QOL impact suffered by chronic OSA candidates.
摘要：
由SARS-CoV2引起的COVID-19已经达到大流行的程度。对新冠肺炎的恐惧阻止了许多人放弃寻求及时医疗帮助的努力。在此设置中，阻塞性睡眠呼吸暂停（OSA）样covid/非covid队列已经出现。非典型病理可以像OSA一样出现，并使临床医生措手不及。伴随着这一系列不称职的人默默地受苦，低估其对生活质量（QOL）的影响是不明智的。确定模仿OSA的病理对生活质量的影响，并评估新冠肺炎是延迟呈递的原因。这是一项前瞻性横断面研究。127（否）。最近出现OSA的症状。研究持续时间2020年3月至2021年9月。匹兹堡睡眠质量指数（PSQI）筛查完成。定义了研究标准。计算睡眠参数。给予初级手术干预。无应答者接受CPAP治疗。使用sf-36和SAQLI进行QOL评估。对Covid-19量表(FCV-19S)的恐惧进行量化，以研究时间延迟的原因。计算的相关性。证据等级-3级。97名候选人完成研究。注意人口统计学和人体测量细节。平均范围为43.85±11.39年。男性占主导地位。总体AHI-19.73±8.72。sf-36/SAQLI对生活质量的中等影响。78n主要手术候选人表现良好。多导睡眠图（PSG）和持续气道正压（CPAP）滴定/试验特征19n可用。治疗完成后QOL的统计学显著改善。相关性是有意义的。体重指数（BMI）作为单因素对OSA模拟者没有影响。对新冠肺炎的恐惧严重影响了紧急医疗援助的获取。模仿非典型气道病理的OSA可能不仅从手术角度而且从患者的QOL需要紧急治疗。相反,这些也揭示了亚临床OSA，特别是在低/正常BMI的患者中。这类最近发作的OSA，如果幸运的是在尽可能早的演示中被发现，希望不会经历慢性OSA候选人遭受的重大QOL影响。
